Titanium implants were successfully introduced by P.-I. Brånemark and co-workers in 1969 for the rehabilitation of edentulous jaws. After 40 years of research and development, titanium is currently the most frequently used biomaterial in oral implantology, and titanium-based materials are often used to replace lost tissue in several parts of the body.

Devices known as brain-machine interfaces could someday be used routinely to help paralyzed patients and amputees control prosthetic limbs with just their thoughts.

UCL Business (UCLB) has announced the sale of Stanmore Implants Worldwide (SIW) for around £10 million.

Results published today in FASEB (the journal of the Federation of American Societies for Experimental Biology) by researchers at Columbia University, including Jeremy Mao of the Columbia College of Dental Medicine, demonstrate a novel way of using porous structures as a drug-delivery vehicle that can help boost the integration of host tissue with surgically implanted titanium.

A small device implanted in the skull that detects oncoming seizures, then delivers a brief electrical stimulus to the brain to stop them is under study at the Medical College of Georgia.

Purdue University researchers have developed new miniature devices designed to be implanted in the brain to predict and prevent epileptic seizures and a nanotech sensor for implantation in the eye to treat glaucoma.

A more efficient way of detecting loosened artificial hip implants, which affect thousands of people every year, has been developed.

A world leader in medical implants calls for a rethink in our approach to building medical implants.

More than half a million people in the European Union and a million in the United States suffer from disorders in or serious defects of some part of their bone structure. Operations involving grafts or implants, required to mitigate the damage, depend decisively on the materials used.